CellSource Co., Ltd.

TSE:4880.T

608 (JPY) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Revenue 971.317849.1861,013.681,113.711,054.1571,173.5161,104.4161,235.5161,111.0821,059.531,400.8421,175.967876.103820.917817.967761.14720.442622.683543.514425.672441.861444.428439.385
Cost of Revenue 415.794383.339716.148418.721393.073409.709350.729346.833347.914280.067374.028334.789261.126239.585242.335222.773209.662173.437162.066146.303160.702127.448129.23
Gross Profit 555.523465.847297.532694.989661.084763.807753.687888.683763.168779.4631,026.814841.178614.977581.332575.632538.367510.78449.246381.448279.369281.159316.98310.155
Gross Profit Ratio 0.5720.5490.2940.6240.6270.6510.6820.7190.6870.7360.7330.7150.7020.7080.7040.7070.7090.7210.7020.6560.6360.7130.706
Reseach & Development Expenses 000022.50715.45913.52515.87216.19226.86421.67522.63826.06117.18811.11821.92122.7110100007
General & Administrative Expenses 000000820008200065000680000
Selling & Marketing Expenses 00000010300010000093000122000198
SG&A 476.282528.014556.5588.338562.963542.486561.876488.936438.925401.311372.851370.526342.541319.767250.783260.214245.813269201214218192198
Other Expenses 000000-0.0040.4370000002.062-0.02401218.6830.0230.0080.0484.939
Operating Expenses 476.282528.014556.5588.338585.47557.945575.397504.808455.117428.175394.522393.164368.602336.955261.896282.135268.524269.024218.683214.426217.938192.354211.112
Operating Income 79.241-62.167-258.968106.65175.614205.862178.286383.875308.051351.287632.287448.014246.375244.376313.731256.234242.255180.221162.76164.94463.222124.62499.04
Operating Income Ratio 0.082-0.073-0.2550.0960.0720.1750.1610.3110.2770.3320.4510.3810.2810.2980.3840.3370.3360.2890.2990.1530.1430.280.225
Total Other Income Expenses Net 1.214.7914.5462.938151.4426.856-23.18241.89511.201-11.7314.7062.6734.6460.5620.944-0.01512.4050.5910.027-2.0090.427-1.188-18.613
Income Before Tax 80.451-57.376-254.422109.589227.056212.718155.104425.77319.252339.556636.993450.687251.021244.938314.675256.219254.66180.813162.78862.93563.648123.43680.427
Income Before Tax Ratio 0.083-0.068-0.2510.0980.2150.1810.140.3450.2870.320.4550.3830.2870.2980.3850.3370.3530.290.30.1480.1440.2780.183
Income Tax Expense 23.813-11.911-118.15435.35770.98168.816-92.9160.694125.234123.512208.276169.95198.39889.17191.48196.79998.99167.747.09222.99822.72945.90626.546
Net Income 56.636-45.464-136.26874.231156.076143.901248.004265.077194.017216.044428.716280.736152.624155.766223.195159.419155.67113.112115.69739.93740.91977.52953.881
Net Income Ratio 0.058-0.054-0.1340.0670.1480.1230.2250.2150.1750.2040.3060.2390.1740.190.2730.2090.2160.1820.2130.0940.0930.1740.123
EPS 2.86-2.3-6.883.757.887.2712.8814.0310.3811.5622.9415.038.188.3612.18.648.446.136.272.172.314.373.04
EPS Diluted 2.86-2.3-6.883.737.847.2312.7813.810.111.2422.3114.627.958.1112.18.648.445.896.272.172.314.083.04
EBITDA 126.907-4.424-202.15143.916257.796238.739180.453441.182331.173351.107650.458462.995261.952253.667323.85267.363262.314180.861180.58063.724141114
EBITDA Ratio 0.131-0.005-0.1990.1290.2450.2030.1630.3570.2980.3310.4640.3940.2990.3090.3960.3510.3640.290.3320.1880.1440.3170.259